In-Hospital Neurologic Complications in Adult Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation: Results From the Extracorporeal Life Support Organization Registry

  • Roberto Lorusso
    Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Fabio Barili
    Cardiac Surgery Unit, Cardiac Surgery, Santa Croce Hospital, Cuneo, Italy.
  • Michele Di Mauro
    Institute of Cardiology, University of L’Aquila, L’Aquila, Italy.
  • Sandro Gelsomino
    Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Orlando Parise
    Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Peter T. Rycus
    Extracorporeal Life Support Organization (ELSO), University of Michigan, Ann Arbor, MI.
  • Jos Maessen
    Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Thomas Mueller
    Department of Internal Medicine II, University Hospital of Regensburg, Regensburg, Germany.
  • Raf Muellenbach
    ECMO Department, University of Wurzburg, Wurzburg, Germany.
  • Jan Belohlavek
    Coronary Care Unit, Cardiovascular Medicine, General Teaching Hospital, Charles University, Prague, Czech Republic.
  • Giles Peek
    Cardio-Thoracic Surgery Department, Glenfield Hospital, Leicester, United Kingdom.
  • Alain Combes
    Internal Medicine Intensive Care Unit, La Pitiè Hospital, Paris, France.
  • Bjorn Frenckner
    Division of Pediatric Surgery–Karolinska Hospital, Stockholm, Sweden.
  • Antonio Pesenti
    Anesthesiology Department–University of Milan, San Gerardo Hospital, Monza, Italy.
  • Ravi R. Thiagarajan
    Cardiac Intensive Care Unit, Boston Children’s Hospital, Boston, MA.

書誌事項

公開日
2016-10
DOI
  • 10.1097/ccm.0000000000001865
公開者
Ovid Technologies (Wolters Kluwer Health)

この論文をさがす

説明

<jats:sec> <jats:title>Objectives:</jats:title> <jats:p>To elucidate the epidemiology, complication profiles, hospital outcome, and predisposing factors of CNS complications occurring during venoarterial extracorporeal membrane oxygenation in adults.</jats:p> </jats:sec> <jats:sec> <jats:title>Design:</jats:title> <jats:p>Retrospective analysis of the Extracorporeal Life Support Organization registry.</jats:p> </jats:sec> <jats:sec> <jats:title>Setting:</jats:title> <jats:p>Data reported to Extracorporeal Life Support Organization by 230 extracorporeal membrane oxygenation centers from 1992 to 2013.</jats:p> </jats:sec> <jats:sec> <jats:title>Patients:</jats:title> <jats:p>Patients more than 16 years old supported with a single-run of venoarterial extracorporeal membrane oxygenation.</jats:p> </jats:sec> <jats:sec> <jats:title>Interventions:</jats:title> <jats:p>None.</jats:p> </jats:sec> <jats:sec> <jats:title>Measurements and Main Results:</jats:title> <jats:p>We examined 4,522 adult patients supported with venoarterial extracorporeal membrane oxygenation and included in the Extracorporeal Life Support Organization registry. Venoarterial extracorporeal membrane oxygenation was used for cardiac dysfunction in 3,005 patients (66.5%), cardiopulmonary resuscitation in 877 patients (19.4%), and respiratory failure in 640 patients (14.1%), respectively. Multivariate logistic regression was performed to identify factors independently associated with CNS injury. Neurologic complications occurred in 682 patients (15.1%), and included brain death in 358 patients (7.9%), cerebral infarction in 161 patients (3.6%), seizures in 83 patients (1.8%), and cerebral hemorrhage in 80 patients (1.8%). Multiple CNS complications in the same patient occurred in 70 cases. Hospital mortality in patients with CNS complications was 89%, compared with 57% in patients without (<jats:italic toggle="yes">p</jats:italic> < 0.001). In a multivariable model, age, pre-extracorporeal membrane oxygenation cardiac arrest, the use of inotropes on extracorporeal membrane oxygenation, and post-extracorporeal membrane oxygenation hypoglycemia were shown to be associated with CNS complications.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions:</jats:title> <jats:p>Neurologic complications in adult patients on venoarterial extracorporeal membrane oxygenation support are common and associated with poor survival. Further research should focus on better understanding and management of brain/extracorporeal membrane oxygenation interaction to avoid such catastrophic complications.</jats:p> </jats:sec>

収録刊行物

  • Critical Care Medicine

    Critical Care Medicine 44 (10), e964-e972, 2016-10

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ